Your browser doesn't support javascript.
loading
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer.
Annunziato, Stefano; de Ruiter, Julian R; Henneman, Linda; Brambillasca, Chiara S; Lutz, Catrin; Vaillant, François; Ferrante, Federica; Drenth, Anne Paulien; van der Burg, Eline; Siteur, Bjørn; van Gerwen, Bas; de Bruijn, Roebi; van Miltenburg, Martine H; Huijbers, Ivo J; van de Ven, Marieke; Visvader, Jane E; Lindeman, Geoffrey J; Wessels, Lodewyk F A; Jonkers, Jos.
Affiliation
  • Annunziato S; Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • de Ruiter JR; Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • Henneman L; Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • Brambillasca CS; Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • Lutz C; Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • Vaillant F; Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • Ferrante F; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • Drenth AP; Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • van der Burg E; Transgenic Core Facility, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • Siteur B; Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • van Gerwen B; Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • de Bruijn R; Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • van Miltenburg MH; Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • Huijbers IJ; Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • van de Ven M; Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • Visvader JE; ACRF Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Lindeman GJ; Department of Medical Biology, University of Melbourne, Parkville, VIC, 3010, Australia.
  • Wessels LFA; Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • Jonkers J; Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
Nat Commun ; 10(1): 397, 2019 01 23.
Article in En | MEDLINE | ID: mdl-30674894
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Gene Expression Regulation, Neoplastic / BRCA1 Protein / DNA Copy Number Variations / Carcinogenesis / Mutation Type of study: Prognostic_studies / Systematic_reviews Limits: Animals / Female / Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2019 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Gene Expression Regulation, Neoplastic / BRCA1 Protein / DNA Copy Number Variations / Carcinogenesis / Mutation Type of study: Prognostic_studies / Systematic_reviews Limits: Animals / Female / Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2019 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom